NUMBERS
ONCOLOGY
0
breast cancer diagnosed in the world
new cases reported annually- 2020
new cases reported annually- 2020
Cancer, one of the most challenging and prevalent medical conditions worldwide, demands our utmost attention and care. In 2020, an astounding 19.3 million new cancer cases were reported globally, and this number is projected to rise significantly in the coming years. The battle against cancer continues, and we understand the importance of finding the right medical solutions when traveling abroad for treatment.
Asia, home to diverse cultures and landscapes, has also witnessed an alarming evolution in cancer cases. The region accounted for nearly 50% of all new cancer cases reported in 2020. This surge in numbers highlights the critical need for accessible and reliable medical treatment options in Asia. Unfortunately, approximately half of the diagnosed cases in the region led to mortality, underscoring the urgency of choosing the best medical facilities and services.
At our Medical Tourism Comparator, we aim to empower patients seeking oncology treatments abroad to make informed decisions that prioritize safety and well-being. By providing comprehensive information and transparent comparisons, we aim to reduce potential dangers associated with traveling for medical procedures.
Choosing the right clinic and medical facility can make a significant difference in the outcome of cancer treatment. Factors like budget constraints or inadequate infrastructure in some countries can hinder access to high-quality care. Our platform allows you to compare clinics, services, and treatment options, empowering you to make decisions that prioritize both your health and financial well-being.
By utilizing our Medical Tourism Comparator for oncology, you can gain access to vital information, such as:
– Clinic accreditations and certifications, ensuring adherence to international medical standards.
– Doctor qualifications and specialties to find experts in your specific cancer type.
– Success rates and patient testimonials, providing insights into the clinic’s track record.
– Treatment costs and available financing options, helping you plan your medical journey wisely.
– Reviews and ratings from patients who have undergone similar treatments.
At our core, we believe that life should always prevail. Through informed decisions and comparisons, we aim to contribute to positive treatment outcomes and improved quality of life for patients seeking oncology care abroad. Together, let us navigate the path to recovery with confidence and hope.
Procedure | Average savings | Hospital stay | Cleared to fly |
---|---|---|---|
Aneurysm repair | 66.7% | 2 – 6 hrs. | 1 – 3 days |
Angioplasty | 78.7% | 30 min. – 2 hrs. | 2 – 5 days |
Catheter ablation | 71.8% | 2 hrs. | 2 – 5 days |
Coronary artery bypass | 73.5% | 3 – 6 hrs. | 7 – 10 days |
Heart valve repair | 88.2% | 2 – 4 hrs. | 7 – 10 days |
Pacemaker surgery | 88.6% | 1 hr. | 2 – 3 days |
TAVR | 71.8% | 2 – 4 hr. | 7 – 10 days |
A cancer diagnosis can be a traumatic experience for anyone, but it doesn’t have to be a death sentence. Recent advances in medical technology have allowed for many types of cancer to be reduced or eliminated entirely. But the cutting edge of medical treatment is not always available to everyone because of necessary bureaucratic approvals that need to be obtained before a treatment can be performed beyond the experimental stage. Oncology tourism or cancer treatment tourism has become a very popular choice for many cancer sufferers as it offers them treatment options that may not yet be available or legal in their home country.
The most popular destinations for oncology tourism are Germany, France, Spain, Israel, and India.
The reasons why these countries have become so popular for oncology tourism are varied. Germany is known for having the most cutting-edge treatments, France has a reputation for the highest success rate in Europe, Spain has more of a focus on alternative treatments, Israel is a popular choice for its advanced facilities, and India is known for being the cheapest country with up-to-date oncology methods.
Oncology treatment can be extremely expensive, which is one reason why people choose oncology tourism. Some treatment cycles can cost hundreds of thousands of dollars in the United States but those same treatments can be much cheaper depending on where they are performed. It is also common for some of the latest treatments to be unavailable in the U.S. pending FDA approval. When it comes to cancer treatment, waiting is just not an option for some people. That’s why oncology tourism is a great choice for those patients who wish to undergo more experimental or newer treatments that may not be available yet in their home country.
Rising wealth, an increasingly top-heavy population pyramid, more non-communicable diseases (NCDs), and cultural factors have combined to fuel a boom in outbound Chinese medical tourism.
By 2024, the population for urban Chinese aged 40-64 will increase by 108 million from 2014, and 57 million more aged 65 and above, according to Global Demographics. As these groups suffer increasingly from lifestyle diseases that demand cardiovascular and cancer treatments, many of the wealthy among them will seek procedures in the United States or Europe.
And many more will use their new-found wealth to take advantage of plastic surgery, dentistry and wellness programs in Korea or Southeast Asia.
Chinese medical tourists see the United States as the pinnacle of quality for major procedures, such as cancer treatment and cardiac surgery, alongside locations, such as the United Kingdom and Singapore. Korea is very popular for plastic surgery and has seen a 35 percent annual increase in volumes since 2009, primarily patients from China who are lured by the Hallyu or “Korean Wave” cultural phenomenon (hanliu in Mandarin) created by Korean TV and music exports.
Southeast Asian countries also report double-digit increases in the number of mainland medical tourists in recent years, thanks to an influx of Chinese, who make up the fastest growing segment of the market and fourth largest in Malaysia where plastic surgery, dentistry and non-surgical health programs are
popular.
Singapore is also a common destination, thanks to the quality of care, Mandarin language capabilities, and value. Although competitive prices can now be found in other Southeast Asian countries and India, Chinese millionaires are most concerned about securing the best possible care and medical outcomes.
The Stanford Research Institute reports Chinese medical tourists spent USD10 billion in 2014, which is only 2.3 percent of the global total of USD430 bn, suggesting that there is a huge potential for further growth in the market.
Hospitals hoping to tap into this opportunity will need to provide Mandarin speaking staff and nurses, and train clinicians about Chinese perceptions of healthcare, which are still influenced by millennia-old concepts of Traditional Chinese Medicine. On a more practical note, they will also benefit from accepting Chinese credit cards, such as UnionPay and RMB.
Bumrungrad Hospital in Bangkok goes a step further, offering a range of premier and VIP suites, a 24-hour hotline, and embassy contact, airport transfer, reception and a visa application assistance services to create a 5-star hotel-like medical tourism experience.
At the government level, as competitors as diverse as Turkey, India and the Philippines compete for Chinese medical tourists, electronic visa applications, special multiple entry visas, dedicated medical tourist channels at airports, and freedom to transfer money into the country to pay for treatments will all boost a country’s share of what could become the biggest new wave in medical tourism ever.
Pete Read is the CEO of Global Growth Markets. He was a speaker at the Asia-Pacific Medical Tourism Congress, Nov. 14-16, 2015, in Guilin, China. marketing@ggmkts.com
Medical tourism is characterized by people seeking treatment abroad for various medical conditions due to varied reasons, many of whom benefit from specialized care for non-communicable diseases. Conversely, there are associated negative effects such as medical complications and weakened health systems. Currently, there is paucity of scientific evidence on patient-related factors influencing seeking treatment benefits abroad. This study sought to compare patient-related factors associated with choice of cancer treatment center locally or abroad, to understand reasons for seeking treatment outside Kenya.
As a case-control study, 254 cancer patients were randomly sampled to compare responses from those who chose to receive initial treatment abroad or in Kenya. The cases were recruited from Ministry of Health while the controls from Kenyatta National Hospital and Texas Cancer Center. Data was analyzed using SPSS Software Version 21. Descriptive statistics, bivariate and multiple logistic regression analysis was carried out. Level of significance was set at 5%.
Out of 254 respondents, 174 (69.5%) were treated for cancer in Kenya and 80 (31.5%) in India. We found that cost effectiveness was a significant factor for over 73% of all respondents. The study revealed independent predictors for seeking treatment in India were: monthly income higher than US$ 250; every additional month from when disclosure to patients was done increased likelihood by 1.16 times; physician advice (Odds Ratio(OR) 66; 95% Confidence Interval(CI) 7.9–552.9); friends and family (OR 42; 95% CI 7.07–248.6); and perception of better quality of care (OR 22.5; 95% CI 2.2–230.6).
Reasons patients with cancer sought treatment in India are multifactorial. Several of these can be addressed to reverse out-ward bound medical tourism and contribute to improving the in-country cancer healthcare. It will require strengthening the health system accordingly and sensitizing the medical fraternity and general public on the same.
Published online 2022 Sep 21. doi: 10.1371/journal.pone.0273162